Could a soy-based supplement boost heart health in women with kidney disease?
NCT ID NCT07194590
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking equol, a compound from soy, for 12 weeks can improve blood vessel function in postmenopausal women with moderate chronic kidney disease (stages 3-4). The goal is to lower their high risk of heart disease. Researchers will measure changes in artery flexibility and blood pressure in 74 women aged 50 and older.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PRESSURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal implant may tackle pain and blood pressure together
- Can one avocado a day sharpen the aging brain?
- Could a brain zap and a workout sharpen the schizophrenic mind?
- Wrist-Worn blood pressure monitor put to the test against gold standard
- AI and a pulse oximeter may predict dangerous blood pressure swings in spinal cord injury
- Could a simple cuff replace needles for blood pressure monitoring?